Description of service

PHE will provide access to the ferret model of influenza at BSL2 as part of TNA8 Animal models platform.


12 weeks, maximum study duration

3-4 months of advance notice required before start of study


Anthony Marriott

00441980 612371

Services do NOT include

Optional: additional groups of ferrets for lung/tissues; virus neutralisation titres; histopathology; immunogenicity studies.

Possible Output

Report detailing clinical parameters of disease, virology (nasal wash virus titres), serology, IFN-gamma ELISA, IFN-gamma Elispot.

Sample Requirements - input of users

User to provide vaccine samples of suitable purity and quality for vaccination of ferrets. Documentation should be provided confirming quality control (freedom from pyrogens, freedom from bacterial contamination). User to provide antigen for immunological assays if require

Lead Scientist

Anthony Marriott

Related services

Users may wish to use analytics services to assess purity of vaccine candidates (TNA3).

Immunogenicity and chanllenge studies in ferrets

Cost coverage opportunities

 If you are interested in this service please contact the service provider directly

Upon provider's availability

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon
Subscribe to TRANSVAC´s Mailing list

© 2021 European Vaccine Initiative. Designed by European Vaccine Initiative